# CREST (NCT04165317)

> A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04165317
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Pfizer
- Conditions: Non-muscle Invasive Bladder Cancer
- Interventions: PF-06801591; Bacillus Calmette-Guerin
- Enrollment: 1068
- Primary outcome: Cohort A: Event Free Survival (EFS) as Assessed by the Investigator: Arm A Versus Arm C

## Indexed commentary on CREST so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 5 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=crest-nct04165317